期刊文献+

肝细胞生长因子及其受体在蛋白尿慢性肾纤维化大鼠肾组织中表达的动态变化 被引量:3

Expression of hepatocyte growth factor and c-Met in rats with chronic renal fibrosis
下载PDF
导出
摘要 目的探讨蛋白尿慢性肾纤维化大鼠肾组织中肝细胞生长因子(HGF)及其受体c-Met表达和意义。方法36只♂SD大鼠随机分为对照组和蛋白尿慢性肾纤维化组,应用多柔比星(4mg/kg)尾静脉注射1周后重复的方法建立大鼠蛋白尿慢性肾纤维化模型,分别于第1次多柔比星注射后第4、7、10、13周末收集标本,观察大鼠24h尿蛋白、血清白蛋白(ALB)、血甘油三酯(TG)、总胆固醇(TC)及病理变化。应用Western blot与免疫组化技术分别检测肾组织HGF及c-Met蛋白表达。结果①模型组大鼠24h尿蛋白、ALB、TG、TC明显高于对照组(P<0.01)。②4周末时模型组尿蛋白较对照组明显增多,随着病程进展,肾小球硬化程度加重,第7周肾小球硬化呈局灶节段性分布,肾小球肥大,肾小囊扩张,肾小球有不同程度的硬化,间质可见明显纤维化和局灶性炎细胞。10周及13周肾纤维化程度及面积加重。③肾脏HGF及c-Met表达4周时较对照组增加(P<0.01),7周时开始降低,并随病程呈进一步降低。结论肾纤维化过程中,肾脏HGF及c-Met的表达早期上升是一种有益的防御反应;后期HGF、c-Met表达逐渐降低,肾纤维化逐渐发展。肾脏HGF及c-Met表达的下降可能是慢性肾纤维化发展的机制之一。 Objective To study the expression of hepatocyte growth factor(HGF)and its receptor c-Met in adriamycin-induced glomerulosclerosis rats model. Methods 36 male SD rats were randomly divided into the normal control group and chronic glomerulosclerosis rats model group induced by intravenous injection of adriamycin 4 mg/ kg, again after a week. At the end of 4 th,7 th, 10 th, 13 th week after the first injection, the sample were collected. The blood and urine biochemistry examination , pathological changes, the expression of HGF and c-Met were observed. Results ① 24 hours urine protein excretion, ALB, TG, TC in pathologic model rats gradully increased ( P 〈 0. 01 ). ② At the 7th week, lightscope showed significant Bowman's capsule expansion, glomeruli hypertrophy, focal fibrosis in renal tubulointerstitium in glomerulosclerosis rats model group, and at the end of 10th and 13th weeks, these abnormal changes were obviously aggravated. ③ The productions of HGF and c-Met in the glomerulosclerosis model group rats, which were enhanced at the 4th week ( P 〈 0. 01 ), decreased significantly at the 7th week, and were lower and lower as the renal fibrosis progressed. Conclusion In the pathogenesis of chronic renal fibrosis, HGF and c-Met levels initially increased but gradually declined. The decreased expression of HGF and c-Met in renal cortex of glomerulosclerosis model group rats might be one of the mechanisms of chronic renal fibrosis.
出处 《安徽医科大学学报》 CAS 北大核心 2009年第2期182-186,共5页 Acta Universitatis Medicinalis Anhui
基金 安徽省自然科学基金项目(编号:070413074)
关键词 蛋白尿 肝细胞生长因子 原癌基因蛋白c-Met proteinuria hepatocyte growth factor proto-oncogene protein c-Met chronic renal fibrosis
  • 相关文献

参考文献12

  • 1Eddy A A. Molecular basis of renal fibrosis [ J ]. Pediatr Nephrol, 2000,15(3-4) :290 -301.
  • 2郭劲,张伯科,钱浩,王坤,赵珉,梁维龙,阚春明,戴宏.霉酚酸酯对大鼠肾毒血清肾炎肾小球肝细胞生长因子与转化生长因子-β_1表达的影响[J].安徽医科大学学报,2006,41(6):651-654. 被引量:1
  • 3Fogo A B. Animal models of FSGS: lessons for pathogenesis and treatment[ J]. Semin Nephrol,2003,23 ( 2 ) : 161 - 71.
  • 4萨姆布鲁克J,拉塞尔D.分子克隆实验指南(下册)[M].3版.黄培堂译.北京:科学出版社,2002:1713-26.
  • 5Liu Y. Hepatocyte growth factor in kidney fibrosis : therapeutic potential and mechanisms of action [ J ]. Am J Physiol Renal Physio, 2004,281 ( 1 ) :F7 - 16.
  • 6Matsumoto K, Nakamura T. Hepatocyte growth factor : renotropic role and potential the rapeutics for renal diseases [ J ]. Kidney Int, 2001,59(6) :2023 -38.
  • 7Li Y,Wen X, Spataro B C, et al. Hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxi- some proliferator-activated receptor-gamma agonists[ J]. J Am Soc Nephrol,2006,17 ( 1 ) :54 - 65.
  • 8Yang J, Dai C, Liu Y, et al. A novel mechanism by which hepato- cyte growth factor blocks tubular epithelial to mesenchymal transition[ J]. J Am Soe Nephrol,2005,16 ( 1 ) :68 - 78.
  • 9Takabatake Y, Isaka Y, Mizui M, et al. Exploring RNA interference as a therapeutie strategy for renal disease [ J ]. Gene Ther,2005,12 (12) :965 -73.
  • 10Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases [ J ]. Kidney Int, 2001,59(6) : 2023 -38.

二级参考文献12

  • 1梁维龙,钱浩,林辉,赵珉,周典,吴永贵.霉酚酸酯对糖尿病大鼠模型肾组织氧化应激的影响[J].安徽医科大学学报,2004,39(4):278-280. 被引量:4
  • 2Bhan A K, Schneeberger E E, Collins A B,et al. Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis [ J ]. J Exp Med, 1978,148 ( 1 ) : 246 -60.
  • 3Bokemever D, Guqlielmi K E, McGintv A,et al. Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats [ J ]. J Clin Invest, 1997,100 (3) :582 - 8.
  • 4Zhao M H, Chen X M, Chen Y P,et al. Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome[J]. Nephrology,2003, 8(3 ) : 105 -9.
  • 5Ziswiler R, Steinmann N K, Kappeler A, et al. Mycophenolic acid : a new approach to the therapy of experimentalmesangial proliferative glomerulonephritis [ J ]. J Am Soc Nephrol, 1998,9 ( 11 ) :2055 - 66.
  • 6Badid C, Vincent M, McGregor B, et al. Mycophenolate mofetil reduces myofibroblast infiltration and collagen Ⅲ deposition in rat remnant kidney[J]. Kidney Int,2000,58( 1 ) :51 -61.
  • 7Takayuki K, Kazuhiko H, Shinji A, et al. Expression of hepatocyte growth factor is induced by the interaction between human mesangial cells and monocytes [ J ]. Nephron Exp Nephrol, 2003,94(4) :e146-53.
  • 8Barbara J M , Nicole M B,Petronella K, et al. A longitudinal study of TGF-β1 protein levels in renal allograft recipients converted fromCsA to MMF or AZA[ J]. Clin Transplantation,2000,14( 1 ) :66 -9.
  • 9Zhang X H,Yang J W,Li Y J, et al. Both Spl and smad participate in mediating TGF-β1 -induced HGF receptor expression in renal epithelial cells [ J]. Am J Physiol Renal Physiol, 2005,288(1) :F16-26.
  • 10Mizuno S, Nakamura T. Suppressions of chronic glomerular injuries and TGF-β1 production by HGF in attenuation of murine diabetic nephropathy[ J ]. Am J Physiol Renal Physiol, 2004,286 ( 1 ) :F134 -43.

共引文献2

同被引文献39

  • 1李国霞,黄文政,何永生.扶肾降浊法治疗慢性肾衰竭80例临床观察[J].山东中医杂志,2005,24(4):207-209. 被引量:9
  • 2刘震,周树录,谭建三,王峥,王增贵,张晓东,余运成.大鼠系膜增殖型肾小球肾炎模型的改进[J].华西医科大学学报,1996,27(2):182-184. 被引量:58
  • 3Yu H T. Progression of chronic renal failure [ J ]. Arch Int Med, 2003,163(12) :1417 -29.
  • 4Dixon A, Wells C C, Singh S, et al. Renoprotective Effects of a Selective Estrogen Receptor Modulator, Raloxifene, in an Animal Model of Diabetic Nephropathy [ J ]. Am J Nephrol, 2007,27 ( 2 ) : 120 - 8.
  • 5Fogo A B. Animal models of FSGS:lessons for pathogenesis and treatment [ J]. Semin Nephro1,2003,23 (2) : 161 - 71.
  • 6Priraini L, Salinas-Madrigul L, Koss M N. Evaluation of percutaneous renal biopsy [ M ]//sommers sc, ed. Kidney Pathology Decennial. New York : Appleton Century Crofts, 1975 : 109 - 63.
  • 7Picard N, Baum O, Vogetseder A, et al. Origin of renal myoWbroblasts in the model of unilateral ureter obstruction in the rat [ J]. Histochem Cell Bio ,2008,130( 1 ) : 141 - 55.
  • 8Yang J W, Liu Y H. Dissection of Key Events in Tubular Epithelial to Myofibroblast Transition and Its Implications in Renal Interstitial Fibrosis [ J ]. Kidney Int ,2007,72 ( 3 ) :269 - 73.
  • 9Johnson R J,Iida H,Alpers C E,et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth nmscle actin is a marker of mesangial cell proliferation [ J ]. J Clin Invest, 1991,87 ( 3 ) : 847 - 58.
  • 10Martine B, Harmsen M C, van-Luyn M J, et al. Bone-marrow derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen Ⅰ after ischemia/reperfusion in rats[ J]. Am J Soc Nephrol,2007,18 ( 1 ) : 165 - 75.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部